WallStSmart

Afya Ltd (AFYA)vsCovista Inc. (CVSA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Afya Ltd generates 98% more annual revenue ($3.77B vs $1.91B). AFYA leads profitability with a 20.1% profit margin vs 12.3%. AFYA trades at a lower P/E of 8.5x. AFYA earns a higher WallStSmart Score of 62/100 (C+).

AFYA

Buy

62

out of 100

Grade: C+

Growth: 6.0Profit: 8.5Value: 8.3Quality: 5.8
Piotroski: 5/9

CVSA

Buy

56

out of 100

Grade: C

Growth: 4.0Profit: 7.5Value: 6.3Quality: 6.5
Piotroski: 6/9Altman Z: 3.09
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AFYAUndervalued (+74.6%)

Margin of Safety

+74.6%

Fair Value

$61.03

Current Price

$14.44

$46.59 discount

UndervaluedFair: $61.03Overvalued

Intrinsic value data unavailable for CVSA.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AFYA4 strengths · Avg: 9.8/10
P/E RatioValuation
8.5x10/10

Attractively priced relative to earnings

Price/BookValuation
1.4x10/10

Reasonable price relative to book value

Operating MarginProfitability
38.9%10/10

Strong operational efficiency at 38.9%

Profit MarginProfitability
20.1%9/10

Keeps 20 of every $100 in revenue as profit

CVSA2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
3.0910/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.888/10

Growing faster than its price suggests

Areas to Watch

AFYA2 concerns · Avg: 3.5/10
EPS GrowthGrowth
3.2%4/10

3.2% earnings growth

Market CapQuality
$1.25B3/10

Smaller company, higher risk/reward

CVSA2 concerns · Avg: 3.0/10
Revenue GrowthGrowth
4.5%4/10

4.5% revenue growth

EPS GrowthGrowth
-24.6%2/10

Earnings declined 24.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : AFYA

The strongest argument for AFYA centers on P/E Ratio, Price/Book, Operating Margin. Profitability is solid with margins at 20.1% and operating margin at 38.9%.

Bull Case : CVSA

The strongest argument for CVSA centers on Altman Z-Score, PEG Ratio. PEG of 0.88 suggests the stock is reasonably priced for its growth.

Bear Case : AFYA

The primary concerns for AFYA are EPS Growth, Market Cap.

Bear Case : CVSA

The primary concerns for CVSA are Revenue Growth, EPS Growth.

Key Dynamics to Monitor

AFYA profiles as a mature stock while CVSA is a value play — different risk/reward profiles.

CVSA carries more volatility with a beta of 0.62 — expect wider price swings.

AFYA is growing revenue faster at 8.2% — sustainability is the question.

AFYA generates stronger free cash flow (418M), providing more financial flexibility.

Bottom Line

AFYA scores higher overall (62/100 vs 56/100), backed by strong 20.1% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Afya Ltd

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Afya Limited, is a medical education group in Brazil. The company is headquartered in Nova Lima, Brazil.

Visit Website →

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Want to dig deeper into these stocks?